Vita Coco COO Burth reports Rule 10b5-1 option exercises, sales
Rhea-AI Filing Summary
Vita Coco Company, Inc. (COCO) Chief Operating Officer Jonathan Burth reported option exercises and share sales of company stock. On 11/17/2025, he exercised 17,666 stock options at an exercise price of $10.178 per share and sold 17,666 common shares in a separate transaction at a weighted average price of $48.684 per share under a Rule 10b5-1 trading plan. The same day, he exercised an additional 20,000 options at $10.178 per share and sold 20,000 shares at a weighted average price of $50.019 per share. Following these transactions, he directly held 76,127 shares of common stock and a significant number of vested and unvested non-qualified stock options with various exercise prices and expiration dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 17,666 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 20,000 | $0.00 | -- |
| Exercise | Common Stock | 17,666 | $10.178 | $180K |
| Sale | Common Stock | 17,666 | $48.684 | $860K |
| Exercise | Common Stock | 20,000 | $10.178 | $204K |
| Sale | Common Stock | 20,000 | $50.019 | $1.00M |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.55 to $49.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
FAQ
What insider transaction did Vita Coco (COCO) report for its COO?
Chief Operating Officer Jonathan Burth reported exercises of stock options and related sales of common stock on 11/17/2025, all disclosed on a Form 4.
What prices were involved in the COO’s Vita Coco (COCO) transactions?
The options had an exercise price of $10.178 per share. The related sales were at weighted average prices of $48.684 per share and $50.019 per share, respectively.
What types of derivative securities does the Vita Coco (COCO) COO hold?
He holds several non-qualified stock options with exercise prices ranging from $10.178 to $33.36 per share and expiration dates between 12/16/2029 and 03/04/2035, some of which are fully vested and others vest in installments.